Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 19, 2022
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
[ Tue, Jul 19th 2022
] - WOPRAI
Douglas Tsao Initiated (APLS) at Strong Buy and Held Target at $75 on, Jul 19th, 2022
Douglas Tsao of HC Wainwright & Co., Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $75 on, Jul 19th, 2022.
Douglas has made no other calls on APLS in the last 4 months.
There are 5 other peers that have a rating on APLS. Out of the 5 peers that are also analyzing APLS, 1 agrees with Douglas's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $44 on, Thursday, May 5th, 2022
These are the ratings of the 4 analyists that currently disagree with Douglas
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $84 on, Tuesday, May 24th, 2022
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $102 on, Thursday, May 5th, 2022
- Elemer Piros of "Roth Capital" Downgraded from Hold to Strong Sell and Held Target at $40 on, Thursday, April 14th, 2022
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Monday, April 4th, 2022
